NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Conditions
Type 2 Diabetes · Diabetic Cardiomyopathy · Heart Failure · Cardiometabolic Diseases
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Contact: Study coordinator (Ambarish Pandey, MD) · ambarish.pandey@utsouthwestern.edu · 214-645-9868